Ricerca
Didattica
Soluzioni
Accedi
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Surgery,
Immuno-Oncology Program,
Brown Cancer Center,
Department of Microbiology and Immunology,
School of Medicine,
Immuno-Oncology Program, Brown Cancer Center
Kavitha Yaddanapudi has not added Biography.
If you are Kavitha Yaddanapudi and would like to personalize this page please email our Author Liaison for assistance.
Cancer vaccines: Looking to the future.
Oncoimmunology Mar, 2013 | Pubmed ID: 23802081
Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?
PloS one , 2012 | Pubmed ID: 22860107
Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
The Journal of biological chemistry Nov, 2012 | Pubmed ID: 22988252
Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2013 | Pubmed ID: 23390297
MIF family members cooperatively inhibit p53 expression and activity.
PloS one , 2014 | Pubmed ID: 24932684
Multi-peptide immunotherapeutic vaccine for renal cell carcinoma: getting the troops all worked up.
Translational andrology and urology Dec, 2012 | Pubmed ID: 25221745
Stromal-dependent tumor promotion by MIF family members.
Cellular signalling Dec, 2014 | Pubmed ID: 25277536
The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.
Oncotarget Mar, 2015 | Pubmed ID: 25609198
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
Cancer immunology research Feb, 2016 | Pubmed ID: 26603621
MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes.
Genomics data Mar, 2016 | Pubmed ID: 26981417
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
Oncotarget Dec, 2016 | Pubmed ID: 27566591
Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin.
F1000Research , 2016 | Pubmed ID: 28299174
The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cells.
Oncotarget Apr, 2017 | Pubmed ID: 28424421
Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy.
Journal of leukocyte biology 09, 2017 | Pubmed ID: 28546500
Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.
Cancer biology & therapy 03, 2018 | Pubmed ID: 29252087
Vaccination with induced pluripotent stem cells confers protection against cancer.
Stem cell investigation , 2018 | Pubmed ID: 30148156
Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention.
Oncoimmunology , 2019 | Pubmed ID: 30723593
Simultaneous Quantification of Nucleosides and Nucleotides from Biological Samples.
Journal of the American Society for Mass Spectrometry Jun, 2019 | Pubmed ID: 30847833
Detection of Inflammation-Related Melanoma Small Extracellular Vesicle (sEV) mRNA Content Using Primary Melanocyte sEVs as a Reference.
International journal of molecular sciences Mar, 2019 | Pubmed ID: 30870978
Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope.
Frontiers in immunology , 2020 | Pubmed ID: 32765528
Cancer Vaccines: Promising Therapeutics or an Unattainable Dream.
Vaccines Jun, 2021 | Pubmed ID: 34207062
University of Louisville
Shuhan Meng1,2,
Aaron G. Whitt1,2,3,
Allison Tu2,
John W. Eaton1,2,3,
Chi Li1,2,3,
Kavitha Yaddanapudi4,5,6
1Department of Pharmacology and Toxicology, University of Louisville,
2Experimental Therapeutics Program, Brown Cancer Center, University of Louisville,
3Department of Medicine, University of Louisville,
4Department of Surgery, University of Louisville,
5Immuno-Oncology Program, Brown Cancer Center, University of Louisville,
6Department of Microbiology and Immunology, University of Louisville
Connor S. Centner1,
Emily M. Murphy1,
Bryce F. Stamp2,
Mariah C. Priddy1,
John T. Moore1,
Paula J. Bates2,
Michael A. Menze3,
Kavitha Yaddanapudi2,
Jonathan A. Kopechek1
1Department of Bioengineering, University of Louisville,
2School of Medicine, University of Louisville,
3Department of Biology, University of Louisville
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
Copyright © 2024 MyJoVE Corporation. Tutti i diritti riservati